Clinical laboratory markers remain essential tools for assessing systemic inflammation and disease progression. CRP, an IL-6-driven acute-phase reactant produced by the liver, is frequently elevated in severe influenza, including cases complicated by acute respiratory distress syndrome (ARDS). This evidence concerns the gene CRP and acute respiratory distress syndrome.